Novartis Pursues ‘Invented In China’ Goal At New Shanghai Hub

Helped by Shanghai’s supportive policies to attract talent to back its transformation into a global innovation center by 2030, Novartis recently opened its global third-largest R&D center in the city, as part of a strategy to develop new compounds locally for the worldwide market by tapping into local expertise.

SHANGHAI - In the recent Zhangjiang-Novartis innovation forum “Shaping a Healthy Future”, the Swiss pharma giant Novartis AG held talks with officers from government, academic experts, the research community and industry peers to discuss the blueprint for promoting and building a science and technology innovation center in Shanghai, echoing the official opening of its new R&D campus in the nearby Zhangjiang Hi-Tech Park.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Focus On Asia

More from Scrip